Arcutis Biotherapeutics, Inc.: Form 10-Q/A for the period ended Jun 30, 2023
Filed with the SEC on Sep 15, 2023 and accepted by EDGAR at Sep 15, 2023, 16:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001787306-23-000106. Last ingested by Listed: Oct 28, 2026, 09:04 ET. Listed shows no prices and gives no investment advice.